Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cara Therapeutics Inc CARA

Healthcare Cannabis
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CARA)

Cara Therapeutics Announces Exploration of Strategic Alternatives

GlobeNewswire July 11, 2024

Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica

GlobeNewswire June 12, 2024

Cara Therapeutics Reports First Quarter 2024 Financial Results

GlobeNewswire May 13, 2024

Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024

GlobeNewswire May 6, 2024

Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 2, 2024

Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024

GlobeNewswire March 7, 2024

Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 4, 2024

Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

GlobeNewswire February 12, 2024

Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026

GlobeNewswire January 22, 2024
View More News ››

Opinion & Analysis (NDAQ:CARA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CARA)

Expected earnings - Cara Therapeutics Inc.

Breaking News: $CARA Expected earnings - Cara Therapeutics Inc.Cara Therapeutics Inc. (CARA) is expected to report $-0.29 for Q2...
whytestocks - August 5, 2024

What's Going On With Cara Therapeutics Stock? | Benzinga

JUST IN: $CARA What's Going On With Cara Therapeutics Stock? | BenzingaCara Therapeutics Inc (NASDAQ:CARA) shares are trading higher...
whytestocks - July 11, 2024

CARA - Upate

<< View Post To Watch Video >>
HDavis - November 10, 2021

CARA - Friday Rundown, Monday Expectations

<< View Post To Watch Video >>
HDavis - November 6, 2021

CARA - On The Run Again

<< View Post To Watch Video >>
HDavis - November 1, 2021

CARA - Friday Rundown, Monday Expectations

<< View Post To Watch Video >>
HDavis - October 31, 2021
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ...
View More »